JERSEY CITY, N.J. – Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced a post-hoc analysis of its Phase 3 edaravone study reviewing the results of intravenous (IV) edaravone treatment on disease progression milestones and events among people with amyotrophic lateral sclerosis (ALS). In the analysis, a risk reduction was observed...
Latest News
Toronto, Canada – Researchers at Sinai Health have unearthed vital information about the relationship between insulin levels after eating and long-term heart and metabolic health. The research upends the notion that insulin surge following food intake is a bad thing. On the contrary – it could be an indicator of...
Pohang, South Korea – Gastric cancer ranks among the most widespread diseases in Asian populations, with South Koreans experiencing the third-highest incidence globally in 2020, as reported by the International Agency for Research on Cancer. Recently, a collaborative research effort between Pohang University of Science and Technology (POSTECH) and Yonsei...
Pohang, South Korea – A research team led by Professor Jong Kyoung Kim and Yujin Jeong (PhD candidate), from the Department of Life Sciences at Pohang University of Science and Technology (POSTECH) in collaboration with Professor Yun-Hee Lee and Cheoljun Choi (PhD candidate) from the College of Pharmacy at Seoul...
Researchers at Children’s Hospital Boston have isolated a potent inhibitor of tumor metastasis made by tumor cells, one that could potentially be harnessed as a cancer treatment. Their findings were published in the online Early Edition of the Proceedings of the National Academy of Sciences during the week of June...
HAIFA, Israel and MIAMI, FL — Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care, today announced a promising clinical study in the treatment of Alzheimer’s disease leveraging focused ultrasound (FUS) technology, which has been reported in the latest issue of The New England Journal...
Badalona, Spain – Multiple Sclerosis (MS) is a long-term disease where the immune system mistakenly attacks the protective layer around nerve cells, known as the myelin sheath. This leads to nerve damage and worsening disability. Current treatments, like immunosuppressants, help reduce these harmful attacks but also weaken the overall immune...
Ashley Howard takes her 5-year-old daughter Gabby to see Oak Island pediatrician Jugta Kahai at least every other week. It can be as often as every week depending on Gabby, who has the extremely rare, genetic disorder primary ciliary dyskinesia that gives her constant ear, sinus and respiratory infections. More...
Pittsburgh, PA – In a Nature Metabolism paper published today, researchers from the University of Pittsburgh detail a potential new target and a small-molecule drug candidate for treating Barth syndrome, a rare, life-threatening and currently incurable genetic disease with devastating consequences. Barth syndrome affects about 1 in every 300,000 to...
Utrecht, Netherlands – The Organoid Group (Hubrecht Institute) and the Rare Cancers Genomics Team (IARC/WHO) found a way to grow samples of different types of neuroendocrine tumors (NETs) in the lab. While generating their new model, the researchers discovered that some pulmonary NETs need the protein EGF to be able...